Asian Spectator

Times Advertising

Jemincare initiates phase I clinical trial of anti-SARS-CoV-2 ...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
NANCHANG, China, Jan. 20, 2021 /Xinhua-AsiaNet/-- On January 15, Jemincare Group, a Chinese pharmaceutical company, announced that it has initiated the phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody (JMB2002).Preclinical studies of JMB2002 including pharmacology and toxicity ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Legal Risks Every Business Owner Should Know

Running a business in Australia comes with a degree of legal exposure that many owners underestimate until a problem is already at their door. From contractual disputes to employment matters, the le...

Jerat algoritma: AI perburuk beban ganda ojol dan kurir perempuan di Indonesia

● Sistem AI mengeksploitasi tenaga kerja informal melalui ekstraksi data dan pengalihan risiko kepada mereka.● Algoritma merugikan perempuan karena mengabaikan realitas beban domestik, isu...

Narasi “kebangkitan batu bara” bermunculan efek perang Iran, tapi data menunjukkan fakta sebaliknya

● Di tengah krisis energi global, data menunjukkan penggunaan batu bara dan gas justru turun, sementara energi terbarukan meningkat.● Tren penurunan ekspor baru bara di Indonesia sudah ter...